Calf pre-weaning traits and immunoglobulin response to bovine viral diarrhea virus vaccination by Downum, Whitney et al.
Discovery, The Student Journal of Dale Bumpers College of
Agricultural, Food and Life Sciences
Volume 12 Article 5
Fall 2011
Calf pre-weaning traits and immunoglobulin
response to bovine viral diarrhea virus vaccination
Whitney Downum
University of Arkansas, Fayetteville
A. Hayden Brown Jr.
University of Arkansas, Fayetteville
Jermey G. Powell
University of Arkansas, Fayetteville
E. Beth Kegley
University of Arkansas, Fayetteville
Zelpha B. Johnson
University of Arkansas, Fayetteville
See next page for additional authors
Follow this and additional works at: https://scholarworks.uark.edu/discoverymag
Part of the Agricultural Economics Commons, Animal Diseases Commons, and the Immunology
of Infectious Disease Commons
This Article is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion in Discovery, The Student Journal
of Dale Bumpers College of Agricultural, Food and Life Sciences by an authorized editor of ScholarWorks@UARK. For more information, please
contact scholar@uark.edu, ccmiddle@uark.edu.
Recommended Citation
Downum, Whitney; Brown, A. Hayden Jr.; Powell, Jermey G.; Kegley, E. Beth; Johnson, Zelpha B.; Galloway, Doug B.; Hornsby, James
A.; and Lindsey, Billy R. (2011) "Calf pre-weaning traits and immunoglobulin response to bovine viral diarrhea virus vaccination,"
Discovery, The Student Journal of Dale Bumpers College of Agricultural, Food and Life Sciences. University of Arkansas System Division of
Agriculture. 12:14-18.
Available at: https://scholarworks.uark.edu/discoverymag/vol12/iss1/5
Calf pre-weaning traits and immunoglobulin response to bovine viral
diarrhea virus vaccination
Authors
Whitney Downum, A. Hayden Brown Jr., Jermey G. Powell, E. Beth Kegley, Zelpha B. Johnson, Doug B.
Galloway, James A. Hornsby, and Billy R. Lindsey
This article is available in Discovery, The Student Journal of Dale Bumpers College of Agricultural, Food and Life Sciences:
https://scholarworks.uark.edu/discoverymag/vol12/iss1/5
14   DISCOVERY   •   Vol. 12, Fall 2011
Calf pre-weaning traits and 
immunoglobulin response 
to bovine viral diarrhea virus 
vaccination
Whitney  J. Downum*, A. Hayden Brown Jr.†, Jeremy G. Powell§, E. B. Kegley‡, 
Z. B. Johnson**, D. B. Galloway†† , J. A. Hornsby§§, and B. R. Lindsey‡‡ 
ABSTRACT
Calfhood vaccination for bovine viral diarrhea virus (BVDV) is a relatively new concept, and proto-
cols are evolving. Our objective was to determine effects of BVDV type I vaccination protocol, calf 
behavior (chute score, and chute exit velocity), and gender on calf gain and immunoglobulin (Ig) 
response. Crossbred calves (n = 64) were randomly allotted to one of two vaccination protocols. In 
protocol 1, calves were vaccinated at 60 d of age (d 0) and at weaning (d 147). Calves assigned to 
protocol 2 were vaccinated against BVDV type I at 21 d prior to (d 126) and at weaning (d 147). 
Blood samples were collected from half of the calves in each protocol group on d 0 (60 days of age), 
d 21, d 126 (21 days prior to weaning), and d 147 (at weaning); serum was harvested and Ig titers 
were determined. Titers for BVDV type I were transformed (log base 2) and analyzed using a mixed 
model procedure. Calves vaccinated at d 0 and weaning had larger (P < 0.0001) titers than calves 
vaccinated at d 126 and weaning (7.5 ± 0.36 and 5.1 ± 0.36, respectively). Mean BVDV titers were 
larger (P < 0.0001) on d 147 when compared with d 126, d 21, and d 0 (8.3 ± 0.39, 5.1 ± 0.40, 5.9 ± 
0.39 and 5.7 ± 0.39, respectively). A treatment × day interaction (P < 0.0001) also affected BVDV 
titers. However, BVDV titers were not affected (P > 0.05) by calf gender, chute score, or chute exit 
velocity. Weaning weight and pre-weaning average daily gain (ADG) were not related to BVDV type 
I titers. This study indicated that vaccinating beef calves against BVDV was effective in triggering an 
Ig response. Furthermore, our results suggest that calves should be vaccinated against BVDV type I 
at 60 d of age for greater disease resistance.
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The STudenT Journal of dale BumperS College of agriCulTural, food and life SCienCeS 15
INTRODUCTION
Bovine viral diarrhea virus (BVDV) is an immunosup-
pressive, single-stranded, enveloped RNA virus (Ridpath, 
2002; Glew and Howard, 2001). It is classified in the Pesti-
virus genus of the family Flaviviridae (Bolin and Ridpath, 
1998). Since BVDV is an RNA virus it can mutate rapidly, 
which is why there are several strains, and more to develop 
(Ridpath, 2002). An immunosuppressive virus causes an 
infection that weakens the immune system, which then 
leads to secondary infections from other pathogens.  
Bovine viral diarrhea virus has an economic impact not 
only on the U.S. beef industry, but worldwide (Baker, 1995; 
Houe, 1999). Larson et al., 2002 reported a loss of $15.33 
to $20.16 per cow, which impacted the cow-calf segment 
of the industry. Individual herd outbreaks have estimated 
losses of a few thousand up to one hundred thousand dol-
lars depending on the herd, with estimated losses at the 
national level ranging between $10 and $40 million dollars 
per million calvings (Houe, 2003).  
Bovine viral diarrhea virus infects a high percentage 
of cattle on the national level, and can cause a number 
of clinical diseases ranging from subclinical infection to 
acute fatal mucosal diseases (MD) (Baker, 1995; Houe, 
1995) and various reproductive problems. A BVDV in-
fection during gestation can cause infertility, abortions, 
stillbirths, abnormalities, weak calves and development of 
BVDV persistently infected (PI) calves (Van Campen et 
al., 2000). If the cow is infected with BVDV between 42 to 
120 days of the gestational period, the calves may become 
persistently infected, which means they will persistently 
shed the virus and keep the herd infected (Fulton et al., 
2005, Van Campen et al., 2000) and cause the greatest im-
pact in the feedlot or replacement heifers (Ridpath, 2002). 
Fetuses infected with the virus after 125 days of gestation 
usually are not PI calves.    
Excitable temperament has been shown to negatively 
affect the individual’s immune system (Fell et al., 1999) 
and the cattle industry (Curley et al., 2006). Excitable 
temperament can compromise immune function mak-
ing it difficult for the animal to produce a sufficient re-
sponse when challenged with disease causing organisms 
(Oliphint et al., 2006). Calves with desirable tempera-
ment have greater response to the vaccine (Oliphint et al., 
2006). Calfhood vaccinations have increased subsequent 
growth and decreased subsequent morbidity (Oliphint 
et al., 2006). Average daily gain (ADG), feed conversion, 
morbidity, fertility, and beef quality has been shown to be 
related to temperament (Hoppe et al., 2010). Stimulating a 
calf ’s immune system while it still has a high maternal an-
tibody can be beneficial, since the calves will change from 
maternally derived immunity to long-lasting acquired im-
munity without experiencing a period of vulnerability be-
fore a vaccine can induce protection (Endsley et al., 2003). 
Calfhood vaccination for BVDV is a relatively new con-
cept; additional research seems appropriate. The purpose 
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of this study was to determine the effects of treatment, calf 
age, and age of dam on immunoglobulin (Ig) response to 
BVDV vaccination and to determine the relationship of Ig 
response with chute behavior score (CS), chute exit speed 
(CES), weaning weight, and pre-weaning ADG in cross-
bred beef calves.
MATERIALS AND METHODS
Crossbred calves (n = 64) were Angus sired, born in the 
spring, and weaned in the fall. The cows were Angus based, 
but not straightbred. The group of calves tested averaged 
60 days of age and was located at the Savoy research unit 
at the start of the trial. The calves were stratified by date 
of birth, gender (heifers or steers [castrated at birth]), and 
age of cow then assigned randomly to one of two treat-
ment groups resulting in 32 calves in each treatment. All 
calves were tested using Pyramid 5 vaccine (Boehringer-
Ingelheim Vetmedica, St. Joseph, Mo.) which includes 
BHV, BVDV (Type I and II), PI3, and BRSV. All calves 
were tested for PI BVDV using the AC-ELISA procedure 
(CattleStats, Oklahoma City, Okla.) at branding. 
Calf temperament or chute score (CS) was evaluated 
on a scale of 1-5 where 1 is extremely docile and 5 is ber-
serk frenzy. Calves were then assigned a score of 1-5 to des-
ignate behaviors using the following five-point tempera-
ment rating system, similar to that which Grandin (1998) 
used: 1–calm, no movement, extremely docile; 2–restless 
shifting, slightly nervous; 3–squirming, continuous shak-
ing of chute, down on foreknees; 4–rearing, twisting, con-
tinuous violent struggle, back and forward movement; 
and 5–berserk frenzy.
Serum from jugular samples taken on d 0 (60 d of age), 
d 21, d 126 (21 d prior to weaning), and d 147 (at wean-
ing) from half of the calves in each group (approximately 
16 calves) was harvested for determination of Ig response 
(Table 1). Blood was collected via jugular venipuncture in 
an evacuated tube. Serum was sent to Iowa State Univer-
sity Veterinary Diagnostic Laboratory (Iowa State Univer-
sity, Ames, Iowa) for measurement of Ig response using 
viral neutralization.  
Chute exit velocity (CEV) was calculated as velocity = 
distance (m)/time (s). The CEV of the calf was measured 
electronically (Polaris Wireless Timer; FarmTek, Inc.; Wy-
lie, Texas) over a 1.8-m distance beginning 1.8 m in front 
of the head gate. To trigger the starting and stopping of the 
timer, infrared sensors were used. Chute exit velocity was 
calculated on d 147 of the trial.
Calves were weighed on d 0, d 21, d126, and d 147 of 
the trial to determine pre-weaning ADG, and weaning 
weight was taken on d 147 of the trial.
Statistical Analysis. Titer data were transformed to log 
base 2 (log
2
). Data were analyzed using mixed model pro-
cedures of SAS (SAS Inst. Inc., Cary, N.C.). Fixed effects 
were treatment, sex, and date. Calf was a random effect. 
Chute score (CS), chute exit velocity, weaning weight, and 
pre-weaning ADG were analyzed using CORR procedures 
of SAS. Means were separated with PDIFF option of SAS.
RESULTS AND DISCUSSION
The least square means of CS and CEV by treatments 
did not have a significant change. In treatment 1, calves 
had an average CS of 1.60 m/s ± 0.171 and a CEV of 2.26 
m/s ± 0.241; while calves in treatment 2 had an average CS 
of 1.63 m/s ± 0.171 and a CEV of 2.69 m/s ± 0.254. The 
least square means of CS and CEV by sex did not have a 
significant change. Heifers had an average CS of 1.53 m/s 
± 0.172 and a CEV of 2.31 m/s ± 0.251. While steers had 
an average CS of 1.70 m/s ± 0.178 and a CEV of 2.64 m/s 
± 0.255. A treatment × day interaction (P < 0.0001) was 
found for mean log
2
 of BVDV Type I titer. Mean log
2
 of 
BVDV Type I titer were not affected (P > 0.05) by sex, CEV, 
CS, age of dam, weaning weight, and pre-weaning ADG.  
Calves in treatment 1 were vaccinated against BVDV 
using Pyramid 5 vaccine on d 0 and d147, while calves 
in treatment 2 were vaccinated on d 126 and d 147 of the 
trial. On d 0 and d 21 of the trial, both treatments showed 
high maternal antibody titers. On d 126, calves in treat-
ment 1, which had previously been vaccinated, continued 
to show high serum titers, while treatment 2 titers declined 
at that time. On d 147 of the trial, both treatments showed 
an increase in high serum titers (Table 2). Vaccination of 
beef calves with modified-live virus vaccine at 67 days of 
age was effective in an immunological response (Kirkpat-
rick et al., 2008).  
Vaccinating beef calves at 60 d of age (d 0 of the study) 
against BVDV was effective in triggering an Ig response. 
Bovine viral diarrhea virus vaccination had no effect on 
other production parameters that were studied. Calves 
should be vaccinated against BVDV Type I at 60 d of age 
for greater disease resistance.
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Table 2. Least square means of log 2 type I titer for treatment x day interaction. 
Treatment Day
z
 Mean Log2 BVDV type I titer 
1 0 
                 4.95  ±  0.56d
y
 
 21 
                6.19  ±  0.56bc 
 126 
                 9.30  ±  0.56a 
 147 
                 9.45  ±  0.55a 
   
2 0 
                 6.48  ±  0.55bc 
 21 
                 5.69  ±  0.55ad 
 126 
                 0.99  ±  0.56e 
 147 
                 7.11  ±  0.56b 
Z  
Day (d) 0 =  60 days of age. 
y  
Means with different letters differ (P  <  0.05). 
 
 
Table 1.  Experimental design of treatments, vaccination times,  
and blood collection times (n = 16) during the 147-d study. 
  
60 days of age
z
 
__________________________________ 
 
21 days prior to weaning 
_____________________ 
 
Weaning 
_______________________ 
Treatment d 0 d 21  d 126  d 147 
 May 6 May 27  September 9  September 30 
1 Vaccinated for 
BVDV 
 (Pyramid 5) 
 
Blood collected 
 for titer response 
Blood collected 
for titer response 
 Blood collected 
for titer response 
 
Vaccinated for 
BVDV 
(Pyramid 5) 
 
Blood collected 
for titer response 
____________________________________________________________________________________________________ 
2 Blood collected  
for titer response 
Blood collected 
for titer response 
 
Vaccinated  for 
BVDV 
(Pyramid 5) 
 
Blood collected 
for titer response  
Vaccinated for 
BVDV 
(Pyramid 5) 
 
Blood collected 
for titer response 
Z
 Day (d) 0 = 60 days of age. 
